visikol.com
Get leads like Visikol — and thousands more
Build targeted lists by tech stack, traffic, and more
Visikol: The Micro-Liver Specialists
A 12-person biotech powerhouse disrupting drug discovery with specialized in vitro models
In a biotech industry dominated by billion-dollar pharma giants, Visikol is quietly building a $1.2M revenue engine by solving one of drug discovery's most expensive problems: predicting how drugs cross the blood-brain barrier. With just 12 employees, they're proving that specialization beats scale.
"Visikol isn't trying to be a full-service CRO—they're becoming the world's premier specialist in blood-brain barrier permeability assays."
The Blood-Brain Barrier Breakthrough
Most drug candidates fail because they can't cross the blood-brain barrier (BBB), a $100B+ problem in neuroscience. Visikol's proprietary HUREL primary hepatocyte micro-livers and novel BBB in vitro models offer a rare solution: they can accurately assess penetration kinetics of molecules across the BBB in vitro. This isn't just another CRO service—it's a specialized assay that could save pharmaceutical companies millions in failed clinical trials.
The 12-Person Powerhouse
With revenue at $1.2M, Visikol generates roughly $100K per employee—a remarkable efficiency ratio for a biotech services company. Their traffic data reveals a sophisticated digital strategy: 44% organic search and 42% direct traffic suggests strong brand recognition and SEO dominance in niche keywords like 'delta delta ct analysis' and 'imaging mass cytometry.' They're not buying traffic—they're earning it through technical authority.
The company's tech stack tells a story of pragmatic modernity: Tailwind CSS, Bootstrap, and jQuery coexist with Google Analytics and Zendesk. This isn't a venture-backed rocket ship burning cash on enterprise tools—it's a lean operation focused on delivering scientific results, not software polish. Their social presence across Twitter, LinkedIn, YouTube, Facebook, and Instagram shows they understand their audience: scientists who consume content across platforms.
- HUREL primary hepatocyte models covering over 10 animal species—unusual breadth for a boutique CRO
- Spotlight Blood Brain Barrier Permeability Assay: proprietary methodology that addresses a critical bottleneck
- 44% organic traffic share indicates strong domain authority in a technical, low-volume keyword space
The Specialist's Edge
In biotech, being small and specialized isn't a weakness—it's a competitive moat. Visikol is betting that depth beats breadth, and the data suggests they're right.
What tech stack does Visikol use?
How much traffic does Visikol get?
Traffic & Engagement
Traffic Sources
Where is Visikol's audience located?
What keywords does Visikol rank for?
5 keywordsHow is Visikol's SEO?
Meta Tags
Contract Research Services - Visikol
SpotlightBlood Brain Barrier Permeability Assay Utilizing a novel BBB in vitro model, we offer an in vitro assay capable of assessing the penetration kinetics of molecules passing across the BBB. HUREL Primary Hepatocyte Micro Livers The HUREL portfolio of primary hepatocyte models and services are now part of Visikol which includes over ten animal species
H1 Tags
Schema Types
What is Visikol's revenue?
Who competes with Visikol?
Who works at Visikol?
Loading leads...
What do customers think of Visikol?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Visikol
What is Visikol's Revenue?
What does Visikol do?
How fast is Visikol growing?
What technologies does Visikol use?
Who are Visikol's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Visikol?
Contact Information
Export visikol.com Data
Download the complete tech stack, analytics, leads, and company data for visikol.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About visikol.com
SpotlightBlood Brain Barrier Permeability Assay Utilizing a novel BBB in vitro model, we offer an in vitro assay capable of assessing the penetration kinetics of molecules passing across the BBB. HUREL Primary Hepatocyte Micro Livers The HUREL portfolio of primary hepatocyte models and services are now part of Visikol which includes over ten animal species
Company Overview
visikol.com Social Media
Contact visikol.com
Email Addresses
Phone Numbers
Technology Stack
visikol.com uses 21 technologies across their website including YouTube Embed, Font Awesome, Google Fonts, PHP, and more.
Video
YouTube Embed
Fonts
Font Awesome, Google Fonts
Programming Languages
PHP
CMS
WordPress
Privacy & Consent
Complianz
Marketing Automation
HubSpot
Traffic & Audience
visikol.com receives approximately 14.3K monthly visitors and ranks #1,821,583 globally. The website has a bounce rate of 46% with visitors viewing an average of 1.7 pages per visit. Users spend an average of 1:08 on the site.
The majority of visikol.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is visikol.com?
What technologies does visikol.com use?
How do I contact visikol.com?
What are visikol.com's social media accounts?
Is visikol.com hiring?
How popular is visikol.com?
Related Searches
This page provides publicly available information about visikol.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit visikol.com directly at https://visikol.com.